Agenda - Day 2

There are no agenda items with this track

9:00 am

9:00 am

NETWORKING

Enter Networking Lounge, Connect with your Industry Colleagues

  • Start your day off right and make connections with industry leadership.
  • Join “drop-in” roundtables discussing current and relevant topics.
  • Schedule 1-2-1 video meetings with peers or vendors.
  • Gather essential content and get exclusive offers at virtual exhibit booths.

 

10:00 am

10:00 am

Welcome from your Host

Gain insight into today’s sessions so you can get the most out of your experience and maximize your value. Discuss yesterday’s highlights and map out your day!

 

10:10 am

10:10 am

Opening Keynote: HEALTH CANADA INSIGHTS

What the Pandemic has Taught us About Regulatory Approval Modernization

It has been a challenge for the federal government to update regulations in line with modern changes to drug discovery and market access. The result could be viewed as an onerous regulatory burden or as regulatory clarity paving the way for future opportunities. Take away actionable insights on:

  • The benefits expected from the current federal regulatory modernization project
  • Whether perceived regulatory burdens can be alleviated or reduced
  • How greater clarity on the updated regulations can translate into opportunities for market access

Reduce regulatory burden and leverage regulatory modernization for increased opportunities.

11:00 am

11:00 am

Panel Discussion: VALUE-BASED HEALTHCARE

Uncover the Potential Business Opportunities of Value-Based Healthcare

Value-based healthcare (VBHC) is in the early stages of widespread global adoption. But in Canada there has been little system level progress on the transition to a value-oriented system. Participate in a frank, open discussion as to why this is true, and leave with best practices to:

  • Identify current and future priorities while developing an action plan to address them.
  • Implement lessons from innovative VBHC activity across the country.
  • Boost outcomes, reduce costs and thrive under value-based care.

Realize and recognize the potential benefits of a national VBHC approach for your organization.

11:30 am

11:30 am

Industry Expert: PREDICTIVE ANALYTICS

Predictive Analytics in Patient Support — Fact or Fiction?

There is a lot of buzz around harnessing historic trends and patterns in patient data. Is it hype or reality? Determine if it will impact PSP design and implementation and whether patients will benefit. Take away valuable answers to the following questions:

  • What is predictive analytics in the PSP environment?
  • What is the impact on patient engagement?
  • Can informed analytics impact patient outcomes?

Leverage predictive analytics in patient support to help your products thrive.

12:00 pm

12:00 pm

Presentation: QUEBEC UPDATE

Prepare for the Potential National Implications of Quebec’s New PLA System

In early summer 2021, INESSS announced a change in their guidelines for listing applications. Arm your team with the knowledge to prepare for potential changes, and investigate how these revisions could affect the rest of the country. Develop a blueprint to:

  • Review learnings from the Quebec market to-date.
  • Understand why INESSS/Quebec instituted these particular changes.
  • Gain valuable insight into specifics you may have missed.

Position your company to succeed in an uncertain environment with a solid public PLA strategy.

12:30 pm

12:30 pm

NETWORKING

Build Relationships and Visit Virtual Booths

Expand your network and exchange expertise with your peers. Take advantage of our intuitive platform to deepen your knowledge and connect with industry leaders and experts.

  • Pose your biggest questions to leading solution providers through 1:1 video conversations or chat.
  • Join “drop-in” roundtables in the networking lounge and make connections that last beyond these two days.
  • Experience live demos and test drive new technology. Source leading-edge content from virtual booths.

1:00 pm

1:00 pm

Afternoon Keynote: U.S./CANADA COMPARISONS

Are Patient-Centred Outcomes and a Cost-Effective Drug System Polar Opposites?

The economy may be rebounding, but we will be ‘paying’ for the government’s pandemic spending for years to come. Clarify your understanding of where the U.S. stands in comparison to Canada with respect to drug pricing and ‘profit-taking.’ Gain insight into similarities you may not be aware of, and bring back learnings to:

  • Re-evaluate your assumptions when it comes to price setting.
  • Reassess your current plans for 2022.
  • Improve your chances of success when drafting PLAs.

Maximize the potential of your U.S. dealings with an in-depth understanding of the current state of play.

1:30 pm

1:30 pm

Fireside Chat: U.S. UPDATE

What a Democrat Administration & Congress has in Store for U.S. Drug Pricing

Can President Biden do what Donald Trump and Barack Obama tried to do but failed? Examine the latest rumours swirling around Washington, D.C., regarding ‘forced’ lower drug payments by Medicare and other proposed action. Assess how the following could potentially impact Canadian companies:

  • The passing of H.R. 3, which allows Medicare to negotiate lower prices for prescription drugs and set a $2,000 maximum for out-of-pocket spending
  • The establishment of a health research agency
  • A Republican backlash leading up to the 2022 midterm elections

Get answers to important questions that you won’t find in traditional media sources.

2:00 pm

2:00 pm

Industry Expert: METRIC ANALYSIS

Future-Proof Your Company with Market Access Metrics & Trends for 2022 and Beyond

The pharmaceutical industry has changed significantly over the past decade. This change will only continue to accelerate, affecting nearly the entire market from drug development to access. Prepare your company to adapt to changing market access realities with data-driven insights. Develop an action plan to:

  • Identify the factors likely to impact the timeline of your products’ development to ensure a seamless launch.
  • Analyze how market trends are shaping your future opportunities.
  • Assess how the increasing digitalization of healthcare will impact your relationships with patients and health professionals.

Bolster your market access strategy for the next decade with a data-driven approach.

2:30 pm

2:30 pm

Panel Discussion: HEALTH ECONOMICS

Integrate Health Economics & Outcome Research in Product Development

Cost-effectiveness analysis is commonly undertaken as a one-off exercise. However, the benefits of an iterative use of economic evaluation during the new product development process have been viewed as extremely valuable. Develop a blueprint to:

  • Address complex, systemic health economics and outcomes questions by incorporating big data and system modelling in your approach
  • Ensure health economics is covered every step of the way in new product development

Optimize your product development process with big data, system modelling and outcome research.

3:00 pm

3:00 pm

Panel Discussion: CANADIAN HEALTH & LIFE SCIENCES SECTOR

Canadian Talent — Combating the Health & Life Science “Brain Drain”

Of the 20 leading and emerging fintech hubs globally, Toronto ranked #8, Vancouver #12, Montreal #14 and Calgary #16. Unpack why the same can’t be said for Canada’s health and life sciences sector, and outline what can be done to change that. Take back strategies to galvanize your senior management (and MP) to build a resilient industry by:

  • Using the economic drivers of biotech and fintech as prime examples of successful strategy execution
  • Leveraging learning from key players
  • Incorporating government departmental mandates to strengthen the case for the benefit of all

3:30 pm

3:30 pm

Closing Fireside Chat: INNOVATION & MANUFACTURING IN CANADA

Anticipate the Future of R&D Innovation & Pharma Manufacturing In Canada

The federal government recently invested $200 million to build an mRNA vaccine plant in Mississauga, Ontario. Determine what this means for your organization and for Canadian pharmaceutical manufacturing as a whole. Devise a step-by-step plan of action to:

  • Generate incremental EBITDA while lowering transfer costs.
  • Eliminate the Canadian life sciences “brain drain” to the south.
  • Pioneer home-grown innovation by Canadians for Canadians.

Envision a vastly different future for your Canadian-based company.

4:00 pm

4:00 pm

Conference Summary from your Host

Review key insights and takeaways from the conference. Source a summary of action points to implement in your work.

4:05 pm

4:05 pm

Virtual Happy Hour

  • Get to know fellow delegates in “drop-in” virtual roundtables.
  • Engage in 1:1 video conversation with peers or vendors.
  • Connect with other attendees based on similar interests and business objectives using our “recommend matches” tool.

4:30 pm

4:30 pm

Conference Adjourns

Get the latest news

*Privacy Policy